SCHEMBL581013

SCHEMBL581013

O=C1OC(=O)c2c(F)ccc(F)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
AHR P35869 1/20 0.33
TYMS P04818 1/20 0.33
TTR P02766 1/20 0.32
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
NPC1 O15118 1/20 0.31
CASP3 P42574 1/20 0.31
RAB9A P51151 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29476089 1.00 ALOX15 (0.41) ALOX15TDP1TSHRALDH1A1CA1
SCHEMBL19585963 0.86 ACHE (0.36) ALOX15TDP1TSHRALDH1A1CA1
SCHEMBL18789227 0.86 ALDH1A1 (0.65) ALOX15TDP1TSHRALDH1A1CA1
SCHEMBL855199 0.86 TSHR (0.41) ALOX15TDP1TSHRALDH1A1L3MBTL1
SCHEMBL7483193 0.86 ALOX15 (0.32) ALOX15TDP1TSHRALDH1A1
SCHEMBL855012 0.86 ALDH1A1 (0.41) ALOX15TDP1TSHRALDH1A1TYMS
SCHEMBL23914626 0.83 CA1 (0.31) CA1CA2CA7CA9
SCHEMBL19585504 0.82 AR (0.36) F7F3
SCHEMBL29411884 0.78 ALOX15 (0.50) ALOX15TDP1CA1CA2CA7
SCHEMBL263099 0.78 ALOX15 (0.50) ALOX15TDP1CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 502 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4206205-B1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE BEIJING CO LTD (CN) 2026-03-04 EP claimed
US-20250313672-A1 Method for Preparing Lignocellulose Nanofibril and Composite Materials Reinforced Therewith ZHEJIANG UNIVERSITY (CN) 2025-10-09 US claimed
US-20240363910-A1 ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE CONTAINING SAME NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-10-31 US claimed
EP-4446385-A1 METHODS FOR PREPARING LIGNIN-CONTAINING CELLULOSE NANOFIBRIL AND COMPOSITE MATERIAL REINFORCED WITH SAME Zhejiang University (CN) 2024-10-16 EP claimed
CN-115819630-B Method for preparing high-charge nanocellulose 浙江大学衢州研究院 2024-07-05 CN claimed
WO-2024138534-A1 METHODS FOR PREPARING LIGNIN-CONTAINING CELLULOSE NANOFIBRIL AND COMPOSITE MATERIAL REINFORCED WITH SAME 浙江大学 2024-07-04 WO claimed
CN-116867942-A Method for preparing lignocellulose and reinforced composite material thereof 浙江大学 2023-10-10 CN claimed
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE (BEIJING) CO., LTD. (CN) 2023-09-28 US claimed
WO-2023130423-A1 ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE COMPRISING SAME 宁德新能源科技有限公司 2023-07-13 WO claimed
EP-4206205-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND Primegene (Beijing) Co., Ltd. (CN) 2023-07-05 EP claimed
US-20040215002-A1 Colorant compositions XEROX CORPORATION 2004-10-28 US claimed
US-20040215038-A1 Colorant precursor compositions XEROX CORPORATION 2004-10-28 US claimed
US-20040215022-A1 Colorant compositions XEROX CORPORATION 2004-10-28 US claimed
US-20040214918-A1 Colorant compositions XEROX CORPORATION 2004-10-28 US claimed
US-6790267-B1 METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS XEROX CORPORATION 2004-09-14 US claimed
US-6764541-B1 Colorant compositions XEROX CORPORATION 2004-07-20 US claimed
US-6583248-B1 Methacrylate groups; dental cement AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION 2003-06-24 US claimed
US-6180739-B1 CYCLODEXTRINS WITH ACRYLATE AND ANHYDRIDES AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION 2001-01-30 US claimed
US-5929131-A Polymerizable cyclodextrin derivatives AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1999-07-27 US claimed
US-5792821-A Polymerizable cyclodextrin derivatives AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1998-08-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040215022-A1 Colorant compositions ARSA, TST, IK ALOX15 1757/4885TDP1 4181/4885TSHR 1005/4885
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND DPYD, RPLP2, DHPS ALOX15 3674/4885TDP1 1631/4885TSHR 4332/4885
US-20040215038-A1 Colorant precursor compositions RB1, SULT1A1, CBR1 ALOX15 1248/4885TDP1 3478/4885TSHR 2621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.